Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Heart Rate Monitoring with Chest-worn Biosensor
NCT04682184Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2021
- Primary completion
- Mar 2021
- Countries
- 1
01
Overview
Randomised trial (3 arms), sponsored by Eli Lilly and Company. Primary endpoint: The mean change in heart rate. Started Jan 2021; status: completed.
Beyond the preview
Go deeper on NCT04682184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04682184.